TY - JOUR
T1 - Distinct genetic profile with recurrent population-specific missense variants in Korean adult atypical hemolytic uremic syndrome
AU - Korean TTP Registry investigators, aHUS working group
AU - Yun, Jae Won
AU - Oh, Jisu
AU - Lee, Ki O.
AU - Lee, Seon Ju
AU - Kim, Jung Oh
AU - Kim, Nam Keun
AU - Kim, Jin Seok
AU - Koh, Youngil
AU - Yoon, Sung Soo
AU - Yhim, Ho Young
AU - Jo, Sang Kyung
AU - Park, Yong
AU - Lee, Jung Eun
AU - Park, Jinny
AU - Lee, Jong Wook
AU - Kim, Sun Hee
AU - Kim, Hee Jin
AU - Oh, Doyeun
N1 - Funding Information:
This work was supported by a grant from the Korean Ministry of Education ( 2017R1D1A1B03029582 ).
Publisher Copyright:
© 2020 Elsevier Ltd
PY - 2020/10
Y1 - 2020/10
N2 - Introduction: Atypical hemolytic uremic syndrome (aHUS) is a rare thrombotic microangiopathy (TMA), characterized by micro-angiopathic hemolytic anemia, thrombocytopenia, and renal failure. In more than half of cases, genetic defects leading to overactivation of the alternative complement system have been identified. In this study, we investigated genetic defects in Korean adult patients with aHUS. Materials and methods: Sixty-six Korean adult patients with aHUS were ascertained from the Korean TMA Registry. Genetic variants of 15 aHUS-related genes (eight core genes [CFH, CFB, CFI, CD46, C3, THBD, PLG, and DGKE] and seven candidate genes [CFP, C4BPA, and CHFR1-5]) were analyzed from exome sequencing data. Multiplex ligation-dependent probe amplification of CFH and related genes was performed to detect hybrid genes or large deletions. Results: Thirty patients (45%) had at least one aHUS-related variant (s) in eight core genes (total 40 variant alleles). The most frequently affected gene was CFH (13/40, 32%), followed by THBD (8/40, 20%) and CD46 (7/40, 18%). The two most common variants were Asp486Tyr of THBD (N = 7) and Tyr1058His-Val1060Leu of CFH (N = 5, linked on the same allele), accounting for 30% (12/40). In seven candidate genes, 19 variants were detected. When combined, 40 patients (61%) had at least one variant in 15 core or candidate genes. No patients had anti-CFH Ab or hybrid gene/CFHR1 homozygous deletions. Conclusions: The genetic profile of Korean adult aHUS was unique with recurrent missense variants, demonstrating ethnicity- and age-dependent differences in the genetic background of aHUS.
AB - Introduction: Atypical hemolytic uremic syndrome (aHUS) is a rare thrombotic microangiopathy (TMA), characterized by micro-angiopathic hemolytic anemia, thrombocytopenia, and renal failure. In more than half of cases, genetic defects leading to overactivation of the alternative complement system have been identified. In this study, we investigated genetic defects in Korean adult patients with aHUS. Materials and methods: Sixty-six Korean adult patients with aHUS were ascertained from the Korean TMA Registry. Genetic variants of 15 aHUS-related genes (eight core genes [CFH, CFB, CFI, CD46, C3, THBD, PLG, and DGKE] and seven candidate genes [CFP, C4BPA, and CHFR1-5]) were analyzed from exome sequencing data. Multiplex ligation-dependent probe amplification of CFH and related genes was performed to detect hybrid genes or large deletions. Results: Thirty patients (45%) had at least one aHUS-related variant (s) in eight core genes (total 40 variant alleles). The most frequently affected gene was CFH (13/40, 32%), followed by THBD (8/40, 20%) and CD46 (7/40, 18%). The two most common variants were Asp486Tyr of THBD (N = 7) and Tyr1058His-Val1060Leu of CFH (N = 5, linked on the same allele), accounting for 30% (12/40). In seven candidate genes, 19 variants were detected. When combined, 40 patients (61%) had at least one variant in 15 core or candidate genes. No patients had anti-CFH Ab or hybrid gene/CFHR1 homozygous deletions. Conclusions: The genetic profile of Korean adult aHUS was unique with recurrent missense variants, demonstrating ethnicity- and age-dependent differences in the genetic background of aHUS.
UR - http://www.scopus.com/inward/record.url?scp=85087056653&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087056653&partnerID=8YFLogxK
U2 - 10.1016/j.thromres.2020.06.016
DO - 10.1016/j.thromres.2020.06.016
M3 - Article
C2 - 33213850
AN - SCOPUS:85087056653
SN - 0049-3848
VL - 194
SP - 45
EP - 53
JO - Thrombosis Research
JF - Thrombosis Research
ER -